This aligns with our findings, which showed an elevated GTF2I mRNA in the T2DM+IHD group, suggesting its involvement in the development of IHD among patient with T2DM patients.MicroRNAs have emerged as informative biomarkers for diabetes and its sequelae. This evidence concerns the gene GTF2I and myocardial ischemia.